Spectral (color) mammography shows promising diagnostic benefits for breast cancer, according to PACS and digital mammography developer Sectra.
The company touted results from a study published online in Radiology at the European Congress of Radiology (ECR) in Vienna.
The study used Sectra's photon counting MicroDose mammography system to perform single-shot spectral imaging. Photon counting technology enabled the detection of photons with different energies and colors in a single x-ray exposure, instead of the multiple exposures needed by other technologies, according to Sectra.
The spectral data allow clinicians to determine the tissue type of the breast by the measured photon energies, which could lead to higher cancer detection accuracy.
